IDENTIFICATION OF A SINGLE (FP) RECEPTOR-ASSOCIATED WITH PROSTANOID-INDUCED CA2+ SIGNALS IN SWISS 3T3 CELLS

被引:27
作者
WOODWARD, DF [1 ]
LAWRENCE, RA [1 ]
机构
[1] UNIV EDINBURGH, DEPT PHARMACOL, EDINBURGH, MIDLOTHIAN, SCOTLAND
关键词
PROSTAGLANDINS; RECEPTORS; FIBROBLASTS; CALCIUM; BINDING; FURA-2;
D O I
10.1016/0006-2952(94)90533-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Thus far, the prostanoid FP-receptor has been characterized only on the basis of agonist studies. It is currently classified as a receptor having particular sensitivity to prostaglandin F-2 alpha (PGF(2 alpha)) but with the ability to recognize prostaglandins D-2 and E(2) (PGD(2) and PGE(2)). We have re-examined this concept by studying second messenger Ca2+ signals to PGF(2 alpha), PGD(2) and PGE(2), and performing radioligand binding studies in Swiss 3T3 cells. The same rank order of potency was obtained for both the Ca2+ transient signal and competition for PGF(2 alpha) binding sites. The potency rank order, PGF(2 alpha) > PGD(2) > PGE(2), was identical to that obtained from functional studies in isolated tissues, such as the cat iris. Additional support for the concept that PGF(2 alpha) PGD(2), and PGE(2) interact with a single receptor to elicit a Ca2+ signal was provided by successive addition studies. Thus, cells pretreated with a supramaximal concentration of PGF(2 alpha) exhibited little or no response to subsequent administration of PGD(2) or PGE(2). Likewise, cells pretreated with a large concentration of PGD(2) or PGE(2) exhibited minimal responsiveness to successive addition of the corresponding alternative prostaglandins. Pretreatment with a maximally effective concentration of PGF(2 alpha) PGD(2), or PGE(2) rendered the cells refractory to the FP-receptor selective agonist fluprostenol, which further supports the hypothesis that Ca2+ transient signals in response to prostanoids in Swiss 3T3 cells are mediated by the FP-receptor. The Ca2+ transient responses to PGF(2 alpha), PGD(2), and PGE(2) also exhibited a similar modest reduction when extracellular Ca2+ was removed. Finally, the DP-receptor antagonist BW A868C did not black the Ca2+ transient response to PGD(2), indicating an absence of DP-receptor involvement. Moreover, Ca2+ responses to the thromboxane A(2) mimetic U-46619 were unaffected by the TP-antagonist BM 13505, which indicates no involvement of the TP-receptor. These results support the contention that the FP-receptor has particular sensitivity to PGF(2 alpha) but will also recognize PGD(2) and PGE(2).
引用
收藏
页码:1567 / 1574
页数:8
相关论文
共 28 条
  • [1] STRUCTURAL REQUIREMENTS FOR PROSTAGLANDIN ANALOG INTERACTION WITH THE OVINE CORPUS-LUTEUM PROSTAGLANDIN-F2-ALPHA-RECEPTOR - IMPLICATIONS FOR DEVELOPMENT OF A PHOTOAFFINITY PROBE
    BALAPURE, AK
    REXROAD, CE
    KAWADA, K
    WATT, DS
    FITZ, TA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (14) : 2375 - 2381
  • [2] BITO LZ, 1989, OPHTHALMOL CLIN N AM, V2, P65
  • [3] INTRAOCULAR-PRESSURE REDUCTION WITH PHXA34, A NEW PROSTAGLANDIN ANALOG, IN PATIENTS WITH OCULAR HYPERTENSION
    CAMRAS, CB
    SCHUMER, RA
    MARSK, A
    LUSTGARTEN, JS
    SERLE, JB
    STJERNSCHANTZ, J
    BITO, LZ
    PODOS, SM
    [J]. ARCHIVES OF OPHTHALMOLOGY, 1992, 110 (12) : 1733 - 1738
  • [4] PROSTANOID RECEPTORS - THE DEVELOPMENT OF A WORKING CLASSIFICATION
    COLEMAN, RA
    HUMPHREY, PPA
    KENNEDY, I
    LUMLEY, P
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1984, 5 (07) : 303 - 306
  • [5] COLEMAN RA, 1982, TRENDS AUTONOM PHARM, V3, P35
  • [6] DEASUA LJ, 1983, J BIOL CHEM, V258, P8774
  • [7] FUKAMI K, 1989, J BIOL CHEM, V264, P14985
  • [8] THE CLASSIFICATION OF PROSTAGLANDIN DP-RECEPTORS IN PLATELETS AND VASCULATURE USING BW-A868C, A NOVEL, SELECTIVE AND POTENT COMPETITIVE ANTAGONIST
    GILES, H
    LEFF, P
    BOLOFO, ML
    KELLY, MG
    ROBERTSON, AD
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) : 291 - 300
  • [9] GUSOVSKY F, 1991, MOL PHARMACOL, V40, P633
  • [10] BINDING OF THROMBOXANE A2/PROSTAGLANDIN-H2 AGONISTS TO HUMAN-PLATELETS
    HALUSHKA, PV
    KOCHEL, PJ
    MAIS, DE
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 91 (01) : 223 - 227